Therapeutic plasma exchange (TPE) has been a key immunotherapeutic strategy in
numerous neurological syndromes, predominantly during the acute phase of illness. This …

Objective: To characterize the clinical indications, procedural safety, and outcome of
critically ill children requiring therapeutic plasma exchange. Design: Retrospective …

The objective of this study is to characterize clinical indications, safety and outcome with the
use of TPE in critically ill children. All TPE procedures performed in a tertiary pediatric …

Therapeutic plasma exchange (TPE) is used in the treatment of neurological, hematological,
renal and autoimmune diseases with known or suspected immune pathogenesis. In …

Background Indications for therapeutic plasma exchange (TPE) in the pediatric intensive
care unit (PICU) are expanding. We aimed to study the demographics, clinical indications …

Background Therapeutic plasma exchange (TPE) has evolved to an accepted therapy for
selected indications. However, it is technically challenging in children. Moreover, data on …

Background While complement blockade with eculizumab is recommended as first‐line
therapy of atypical hemolytic uremic syndrome (aHUS), plasma exchanges (PEX) remain the …

Background Apheresis can be associated with adverse events (AEs). Available studies
published on apheresis‐associated AEs lack uniformity of data. Unfortunately, there is no …

Background: Therapeutic plasma exchange (TPE) in atypical hemolytic uremic syndrome
(aHUS) is considered as first line treatment as per current American Society for Apheresis …

Objective: To find the incidence of various complications of therapeutic plasma exchange
(TPE) in ICU admitted children and to determine their association with age, gender, blood …